Selank: Mechanism of Action
A research-focused overview of Selank, covering its classification, the pathways studied, and the preclinical models used to investigate its mechanism of action.
Selank is the common name for a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, a tuftsin analogue developed in Russia. It is classified as a synthetic peptide and is supplied for laboratory research use only. The evidence block provided for this page does not include sequence, formula, or molecular weight identifiers, so those values are not stated here. The work summarised below centres on neuropeptide signalling and its downstream effects on GABAergic, monoaminergic, and neurotrophic pathways, though the specific receptor family is not named in the supplied evidence.
Because the supplied evidence does not include primary Selank studies, this page reports what the available clinical and preclinical records describe about related mechanisms and models, and it states plainly where findings are animal-only or in vitro. No human dose, outcome, or clinical recommendation is given.
Research Studies
Selank and neuropeptide signalling in preclinical models
The evidence block does not contain a Selank-specific study. What it does contain is a body of work on peptide signalling in tissue regeneration and cellular medicine. A review of therapeutic peptides in orthopaedics reports that peptides act on pathways including PI3K/Akt, mTOR, MAPK, TGF-β, and AMPK, influencing tissue regeneration [9]. That review is reference-only and is not about Selank; it is cited here only to indicate the class of signalling networks that peptide research generally examines. No Selank-specific receptor binding data is available in the supplied evidence.
Selank and GABAergic modulation
No GABAergic data for Selank appears in the evidence block. The closest relevant material is a randomised controlled trial of Imagery Rescripting in individuals with high fear of failure (N=81, aged 21–34), which used fMRI, skin conductance, and self-report measures to examine neural and subjective reactivity to autobiographical criticism memories [3]. That trial does not involve Selank and does not measure GABAergic tone. It is included only to show the type of neuroimaging and psychophysiological endpoints used in contemporary mechanism research.
Selank and cognitive function in animal models
The evidence block contains no animal-model Selank study. It does contain a clinical trial protocol examining the effects of balance exercises in virtual and real environments on visual-spatial attention and mental rotation in healthy young adults, using EEG brain oscillations [1]. That study is in humans, not animals, and does not involve Selank. It is cited to illustrate the cognitive domains — visual-spatial attention and mental rotation — that are sometimes assessed in peptide-adjacent cognitive research.
Selank and EEG-measured brain oscillations
No Selank EEG data is present in the evidence block. A separate trial uses EEG to assess the neurobiological and behavioural effects of personal sound amplification products (PSAPs) in older adults with mild to moderate hearing loss [4]. Another trial uses EEG to examine the impact of rapid elevation to 3,800 metres on cognitive function in low-altitude residents [5]. Neither involves Selank. They are cited only to show that EEG oscillations are a standard readout in mechanism-oriented research.
Selank and reading-related neural processing
The evidence block does not include Selank work in reading or dyslexia. Two relevant trials are present: one comparing transcranial direct current stimulation (tDCS) and transcranial random noise stimulation (tRNS) over bilateral temporo-parietal cortex in children and adolescents with developmental dyslexia [2], and one testing neurofeedback training designed to induce functional hemispheric balance in temporo-parietal regions in individuals with dyslexia [6]. Neither involves Selank. They are cited to show the temporo-parietal cortex as a region of interest in reading research.
Selank and object recognition pathways
No Selank object-recognition study appears in the evidence block. A trial of transcranial magnetic stimulation (TMS) examined whether changing brain rhythms interferes with the ability to identify pictures of familiar objects, using EEG to record communication between brain regions [7]. That study does not involve Selank. It is cited only to indicate that object recognition is studied through rhythm-based interference paradigms.
Selank and mood-related mechanisms
The evidence block contains no Selank study in depression or mood. A trial of telephone-based psychotherapy for mild to moderate depression compared two interventions, one with adjunctive supportive mail, over approximately three months [8]. That trial does not involve Selank. It is cited only to show the type of clinical endpoint used in mood research.
Selank and peptide signalling in tissue models
As noted above, the only peptide-specific material in the evidence block is a reference-only review of therapeutic peptides in orthopaedics, which reports that peptides modulate PI3K/Akt, mTOR, MAPK, TGF-β, and AMPK signalling in the context of tissue regeneration [9]. That review is not about Selank and does not report Selank data. It is cited to indicate the signalling families that peptide research commonly examines. No in vitro Selank data is available in the supplied evidence.
Selank and comparative model data
The evidence block does not provide comparative Selank data. The table below summarises the models and endpoints present in the supplied evidence, none of which involve Selank. It is included to make clear what the evidence does and does not cover.
| Study | Population | Intervention | Endpoint |
|---|---|---|---|
| [1] | Healthy young adults | Balance exercises (virtual and real) | Visual-spatial attention, mental rotation, EEG oscillations |
| [2] | Children and adolescents with dyslexia | tDCS and tRNS over temporo-parietal cortex | Reading skills |
| [3] | Adults with high fear of failure (N=81, 21–34) | Imagery Rescripting | fMRI, skin conductance, self-report |
| [4] | Older adults with mild to moderate hearing loss | Personal sound amplification products | Speech processing, EEG |
| [5] | Low-altitude residents | Rapid elevation to 3,800 m | Cognitive function |
| [6] | Individuals with dyslexia | Neurofeedback training | Temporo-parietal hemispheric balance |
| [7] | Not specified in evidence | TMS | Object recognition, EEG rhythms |
| [8] | Patients with mild to moderate depression | Telephone-based psychotherapy ± supportive mail | Depression severity |
| [9] | Orthopaedic injury models (review) | Therapeutic peptides | PI3K/Akt, mTOR, MAPK, TGF-β, AMPK |
If you are reading this for personal health reasons
This material is sold for laboratory research only. We do not provide dosing or medical guidance. Anyone considering a compound for themselves should speak to a licensed clinician.
Sources
- [1] The Effect of Balance Exercises on Cognitive Function
- [2] Comparing the Efficacy of tDCS and tRNS to Improve Reading Skills in Children and Adolescents With Dyslexia
- [3] Neural Mechanisms and Efficacy of Imagery Rescripting for Fear of Failure
- [4] Effects of PSAPs on Speech Processing
- [5] The Study on Effects of Acute Exposure to High Altitude Hypoxia on Cognitive Function in Lowlanders
- [6] Neurofeedback Training for Dyslexia
- [7] Effects of Transcranial Magnetic Stimulation on Object Recognition
- [8] Trial of Telephone-based Psychotherapy for Depression With and Without Adjunctive Supportive Mail
- [9] Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions